These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16198839)

  • 41. [Prognosis after acute coronary syndrome. Lack of difference according to the sex].
    Bounhoure JP; Farah B; Fajadet J; Marco J
    Bull Acad Natl Med; 2004; 188(3):383-97; discussion 397-9. PubMed ID: 15584651
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of secretory phospholipase A2 in acute chest syndrome.
    Kuypers FA; Styles LA
    Cell Mol Biol (Noisy-le-grand); 2004 Feb; 50(1):87-94. PubMed ID: 15040432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study.
    Boekholdt SM; Keller TT; Wareham NJ; Luben R; Bingham SA; Day NE; Sandhu MS; Jukema JW; Kastelein JJ; Hack CE; Khaw KT
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):839-46. PubMed ID: 15692105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
    Mehta RH; Greenbaum AB; Lokhnygina Y; Newby LK; Van De Werf F; Armstrong PW; Pieper KS; Califf RM; Granger CB; Harrington RA
    J Interv Cardiol; 2007 Oct; 20(5):299-306. PubMed ID: 17880325
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anaemia to predict outcome in patients with acute coronary syndromes.
    Ennezat PV; Maréchaux S; Pinçon C; Finzi J; Barrailler S; Bouabdallaoui N; Van Belle E; Montalescot G; Collet JP
    Arch Cardiovasc Dis; 2013; 106(6-7):357-65. PubMed ID: 23806304
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-sensitivity C-reactive protein predicts adverse outcomes after non-ST-segment elevation acute coronary syndrome regardless of GRACE risk score, but not after ST-segment elevation myocardial infarction.
    Raposeiras Roubín S; Barreiro Pardal C; Roubín-Camiña F; Ocaranza Sanchez R; Alvarez Castro E; Paradela Dobarro B; García-Acuña JM; Aguiar Souto P; Jacquet Hervet M; Castromán MJ; Arufe I; Outes B; Reino-Maceiras MV; Abu Assi E; González-Juanatey JR
    Rev Port Cardiol; 2013 Feb; 32(2):117-22. PubMed ID: 23337430
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pentraxin 3 in unstable angina and non-ST-segment elevation myocardial infarction.
    Matsui S; Ishii J; Kitagawa F; Kuno A; Hattori K; Ishikawa M; Okumura M; Kan S; Nakano T; Naruse H; Tanaka I; Nomura M; Hishida H; Ozaki Y
    Atherosclerosis; 2010 May; 210(1):220-5. PubMed ID: 19945702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prognostic value of B-type natriuretic peptide in unstable angina and non-ST-elevation myocardial infarction].
    Molina-Mora MJ; Cabrera-Bueno F; Jiménez-Navarro M; Linde-Estrella A; García-Pinilla JM; Teresa-Galván Ed
    Med Clin (Barc); 2009 Oct; 133(15):569-73. PubMed ID: 19783260
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating levels of secretory- and lipoprotein-associated phospholipase A2 activities: relation to atherosclerotic plaques and future all-cause mortality.
    Lind L; Simon T; Johansson L; Kotti S; Hansen T; Machecourt J; Ninio E; Tedgui A; Danchin N; Ahlström H; Mallat Z
    Eur Heart J; 2012 Dec; 33(23):2946-54. PubMed ID: 22711753
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study.
    Holmes MV; Simon T; Exeter HJ; Folkersen L; Asselbergs FW; Guardiola M; Cooper JA; Palmen J; Hubacek JA; Carruthers KF; Horne BD; Brunisholz KD; Mega JL; van Iperen EPA; Li M; Leusink M; Trompet S; Verschuren JJW; Hovingh GK; Dehghan A; Nelson CP; Kotti S; Danchin N; Scholz M; Haase CL; Rothenbacher D; Swerdlow DI; Kuchenbaecker KB; Staines-Urias E; Goel A; van 't Hooft F; Gertow K; de Faire U; Panayiotou AG; Tremoli E; Baldassarre D; Veglia F; Holdt LM; Beutner F; Gansevoort RT; Navis GJ; Mateo Leach I; Breitling LP; Brenner H; Thiery J; Dallmeier D; Franco-Cereceda A; Boer JMA; Stephens JW; Hofker MH; Tedgui A; Hofman A; Uitterlinden AG; Adamkova V; Pitha J; Onland-Moret NC; Cramer MJ; Nathoe HM; Spiering W; Klungel OH; Kumari M; Whincup PH; Morrow DA; Braund PS; Hall AS; Olsson AG; Doevendans PA; Trip MD; Tobin MD; Hamsten A; Watkins H; Koenig W; Nicolaides AN; Teupser D; Day INM; Carlquist JF; Gaunt TR; Ford I; Sattar N; Tsimikas S; Schwartz GG; Lawlor DA; Morris RW; Sandhu MS; Poledne R; Maitland-van der Zee AH; Khaw KT; Keating BJ; van der Harst P; Price JF; Mehta SR; Yusuf S; Witteman JCM; Franco OH; Jukema JW; de Knijff P; Tybjaerg-Hansen A; Rader DJ; Farrall M; Samani NJ; Kivimaki M; Fox KAA; Humphries SE; Anderson JL; Boekholdt SM; Palmer TM; Eriksson P; Paré G; Hingorani AD; Sabatine MS; Mallat Z; Casas JP; Talmud PJ
    J Am Coll Cardiol; 2013 Nov; 62(21):1966-1976. PubMed ID: 23916927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes.
    Lee KW; Blann AD; Lip GY
    Thromb Haemost; 2005 Nov; 94(5):1077-83. PubMed ID: 16363252
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multimarker risk strategy for predicting 1-month and 1-year major events in non-ST-elevation acute coronary syndromes.
    Bodí V; Sanchis J; Llàcer A; Fácila L; Núñez J; Pellicer M; Bertomeu V; Ruiz V; Chorro FJ
    Am Heart J; 2005 Feb; 149(2):268-74. PubMed ID: 15846264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lipoprotein-associated phospholipase A2 and prognosis after myocardial infarction in the community.
    Gerber Y; McConnell JP; Jaffe AS; Weston SA; Killian JM; Roger VL
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2517-22. PubMed ID: 16902161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.
    Liuzzo G; Biasucci LM; Gallimore JR; Grillo RL; Rebuzzi AG; Pepys MB; Maseri A
    N Engl J Med; 1994 Aug; 331(7):417-24. PubMed ID: 7880233
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22).
    Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP
    Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phospholipase A2 levels in acute chest syndrome of sickle cell disease.
    Styles LA; Schalkwijk CG; Aarsman AJ; Vichinsky EP; Lubin BH; Kuypers FA
    Blood; 1996 Mar; 87(6):2573-8. PubMed ID: 8630425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic relations between inflammatory markers and mortality in diabetic patients with non-ST elevation acute coronary syndrome.
    Sanchez PL; Morinigo JL; Pabon P; Martin F; Piedra I; Palacios IF; Martin-Luengo C
    Heart; 2004 Mar; 90(3):264-9. PubMed ID: 14966041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxidized low-density lipoprotein as a predictor of outcome in patients with unstable coronary artery disease.
    Johnston N; Jernberg T; Lagerqvist B; Siegbahn A; Wallentin L
    Int J Cardiol; 2006 Nov; 113(2):167-73. PubMed ID: 16338010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.